For 17 of these patients, one lymph node metastasis each was also analyzed, which exhibited 1.5-fold lower mean CYP19A1 levels than their matched primary tumors; however, this difference was not significant (P = 0.113; Fig. 3h). The gene discussed is CYP19A1; the disease is metastatic malignant neoplasm in the lymph nodes.